Methodological challenges of performing meta-analyses to compare the risk of hepatocellular carcinoma between chronic hepatitis B treatments-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Methodological challenges of performing meta-analyses to compare the risk of hepatocellular carcinoma between chronic hepatitis B treatments

Published:2022-01 Issue:1 Volume:76 Page:186-194
ISSN:0168-8278
Container-title:Journal of Hepatology
language:en
Short-container-title:Journal of Hepatology

Author:

Choi Won-Mook^ORCID,Yip Terry Cheuk-Fung^ORCID,Lim Young-Suk^ORCID,Wong Grace Lai-Hung,Kim W. Ray^ORCID

Funder

Bayer HealthCare

Gilead Sciences

Publisher

Elsevier BV

Subject

Hepatology

Reference34 articles.

1. Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013;Schweitzer;Lancet,2015

2. Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study;Razavi-Shearer;Lancet Gastroenterol Hepatol,2018

3. EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection;Lampertico;J Hepatol,2017

4. Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance;Terrault;Hepatology,2018

5. Entecavir vs. Tenofovir in hepatocellular carcinoma prevention in chronic hepatitis B infection: a systematic review and meta-analysis;Cheung;Clin Transl Gastroenterol,2020

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tenofovir Is Associated With a Better Prognosis Than Entecavir for Hepatitis B Virus–Related Hepatocellular Carcinoma;Clinical Gastroenterology and Hepatology;2024-07

2. Efficacy of entecavir versus tenofovir disoproxil fumarate in preventing hepatocellular carcinoma—The jury is out;Advances in Digestive Medicine;2024-02-22

3. The power of prevention: how tenofovir and entecavir are changing the game in hepatocellular carcinoma;Hepatobiliary Surgery and Nutrition;2023-12

4. Are the New Nucleos(t)ide Analogs Better than the Old Nucleos(t)ide Analogs?;Clinics in Liver Disease;2023-11

5. Hepatocellular Carcinoma and Hepatitis: Advanced Diagnosis and Management with a Focus on the Prevention of Hepatitis B-Related Hepatocellular Carcinoma;Diagnostics;2023-10-14

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3